Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
Avid Bioservices’ revenue for fiscal year …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Padeliporfin potassium is under clinical development by ImPact Biotech and currently in Phase I for Esophageal Cancer.
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 revenue: $1.74 billion
A Yale-led analysis of the genomes of more than 1 million people has shed light on the underlying biology of cannabis use disorder and its